arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

MIMEDX GROUP, INC.

MDXG
$4.33 ▲ +0.15 (+3.59%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
63 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
81
Health
Excellent
Bullish
auto_awesome

Analytical Summary

MIMEDX GROUP, INC. shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $640.0M
Dividend Yield
Revenue Growth -34.7%
Op. Margin -28.7%
ROIC -6.7%
FCF / Share $-0.07
Trailing P/E
Price / Book 2.9x
FCF Yield
Debt / Equity 0.07
info Valuation on last close. End-of-day price, Aug 7, 2026.

63-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$64.36M
↓ -34.7%
Net Income Profit after all expenses
$-14.84M
↓ -36.6%
Operating Margin Operating profit as % of sales
-28.7%
↓ -5.5% 67th
FCF / Share Free cash flow per share
$-0.07
↓ -635.3%
Long-Term Debt Long-term obligations
$15.71M
↓ -2.4%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
71
Returns
85
Financial Health
89
Cash Quality
80

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 63 quarters